Paragon 28 (FNA) Stock Price

Paragon 28 Price

NYSE·CLOSED
13.09
​
Market closed

Over the last 5 years Paragon 28 grew revenue by 18.4% annually, reaching 244.65 M USD. For Paragon 28, the net margin of -22.3% is down versus 2.4% a few years ago. The consensus 12-month price target for Paragon 28 is 13.26 USD, about 1.3% above where the stock trades today. Of 10 analysts, 6 rate the stock a buy — an overall Buy consensus.

Paragon 28 stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Paragon 28 business model & stock analysis

Paragon 28, Inc. engages in operation of an orthopedic foot and ankle company. The company is headquartered in Englewood, Colorado and currently employs 463 full-time employees. The company went IPO on 2021-10-21. The firm develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products and product families include plates and plating systems, screws, staples, and nails to address all foot and ankle procedures, including fracture fixation, forefoot, or hallux valgus, which includes bunion and hammertoe, ankle, flatfoot, or progressive collapsing foot deformity (PCDF), Charcot foot and Ortho biologics. The company provides a comprehensive portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation. The Company’s suite of surgical solutions comprises 75 product systems, including approximately 9,200 SKUs, which comprises of approximately 6,800 implants, 1,400 instruments and 1,000 disposable and other SKUs. Its products are available in a variety of sizes and configurations to suit the individual patient’s anatomical and surgical requirements.

Frequently asked questions about Paragon 28

Analysts currently set an average price target of 14.28 USD for the Paragon 28 stock (median: 13.26 USD), implying +9.1 % versus the latest price. The consensus is based on 10 analyst ratings.

10 analysts currently rate the Paragon 28 stock: 5 recommend buying, 5 holding and 0 selling.

Converted at the current exchange rate, the Paragon 28 share trades at 11.65 EUR (13.09 USD).

The Paragon 28 share (FNA) is listed on 4 stock exchanges, including: NYSE (FNA), Frankfurt (7GQ.F), München (7GQ.MU), Düsseldorf (7GQ.DU).

The expected revenue of Paragon 28 is 330.54 M USD. This figure is based on current financial data and reflects the company's business performance.

The profit cannot currently be calculated for Paragon 28.

The P/E ratio cannot be calculated for Paragon 28 at the moment.

The price-to-sales ratio (P/S) of Paragon 28 is currently 3.30. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Paragon 28 stock.

The Eulerpool Quality Score for Paragon 28 is 2/10.

The ISIN of Paragon 28 is US69913P1057. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Paragon 28 is A3C5FT. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Paragon 28 is FNA. The ticker symbol is used to trade Paragon 28 shares on the stock exchange.

Fair ValueTerminal
13.74 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
466,001.90 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Oct 21, 2021
ISIN
US69913P1057
Cusip
69913P105
Market capitalization
1.10 B USDSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2025
—
P/Ee 2026
—
P/Ee 2027
-54.13
P/Ee 2028
-216.53
P/S
P/Se
3.75
EV/EBIT
—
P/B Ratio
8.41
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-22.65 %
Last updated Oct 22, 2026, 10:21 PM

Paragon 28 Peer Group

Paragon 28 Ticker

DÜSSELDORF · 7GQ.DUFRANKFURT · 7GQ.FMUNICH · 7GQ.MUNEW YORK · FNA

Paragon 28 FIGI

FNA:US · BBG005914H31FNA:UA · BBG012Q73LB8FNA:UC · BBG012Q73LC7FNA:UN · BBG012Q73LF4FNA:UP · BBG012Q73LG3FNA:UB · BBG012Q73LJ0FNA:UT · BBG012Q73LK8FNA:UM · BBG012Q73LL7FNA:UX · BBG012Q73LM6FNA:UD · BBG012Q73LS0FNA:UF · BBG012Q73LW5FNA:VY · BBG012Q73LX4

All fundamentals and in-depth analysis of Paragon 28

Our stock analysis for Paragon 28 stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Paragon 28. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.